• Genome RNA control for SARS-CoV-2
• Validation of RT-PCR tests
• Any target can be amplified
• Concentration in copies/µl verified
• For diverse molecular test platforms

AMPLIRUN® SARS-CoV-2

The AMPLIRUN® SARS-CoV-2 genome RNA control from vircell is designed to validate RT-PCR assays for the detection of COVID-19 and can be used with various molecular testing platforms.

Product Details

• AMPLIRUN® SARS-CoV-2 from vircell
• Complete genome RNA control for SARS-CoV-2
• Enables the validation of RT-PCR tests for the detection of coronavirus
• Purified nucleic acid, complete microbial genome
• Any target can be amplified
• Precise concentration in copies/µl verified by digital droplet PCR (ddPCR)
• RNA origin from cultured Spanish clinical isolate (Spain)
• Non-infectious material with certificate of inactivation
• Lyophilised presentation
• Can be used with various molecular test platforms
• RUO labelled (for research purposes only)
• Storage at 2-8 °C
• Shelf life after opening: 2 years

Applications

• Quality assurance of the amplification tests
• Detection limit and specificity of the assay
• Batch-to-batch verification assay
• Development, optimisation and validation of new assays
• For training and testing purposes
• Legal compliance and accreditation

Delivery Contents

• 1x Vircell SARS-CoV-2 RNA control (for 12,500-20,000 copies/µl)
• 1x control solution for reconstitution (500 µl)